Cigna earnings beat by $0.04, revenue topped estimates
A 10% owner, TomEnterprise Private AB, associated with Thomas Von Koch, reported purchasing 2,857,142 shares of DiaMedica Therapeutics Inc. (NASDAQ:DMAC) common stock on July 23, 2025. The shares were bought at a price of $3.5, with the total transaction amounting to $9,999,997. The stock has since rallied to $5.05, delivering a 20.8% return in the past week. Analysts see further upside, with price targets ranging from $11 to $14. InvestingPro subscribers track insider transactions alongside comprehensive financial analysis.
Following the transaction, TomEnterprise Private AB and Thomas Von Koch indirectly own 8,383,577 shares. The company maintains a strong liquidity position with a current ratio of 8.02 and holds more cash than debt on its balance sheet. Investors should note the upcoming earnings report scheduled for August 6, 2025.
In other recent news, DiaMedica Therapeutics Inc. announced the completion of a $30.1 million private placement, selling approximately 8.6 million common shares at $3.50 per share to accredited investors. The company received net proceeds of approximately $29.9 million, which will be used to fund its clinical development programs for preeclampsia, fetal growth restriction, and acute ischemic stroke. This private placement did not involve a placement agent and is expected to close around July 23, 2025, subject to customary closing conditions. Additionally, DiaMedica reported positive interim results from its Phase 2 study of DM199 for the treatment of preeclampsia, achieving pre-specified safety and efficacy endpoints. This study demonstrated statistically significant reductions in blood pressure and improved uterine blood flow. Following these results, H.C. Wainwright raised its price target on DiaMedica to $12.00 from $10.00, maintaining a Buy rating on the stock. The firm noted the potential of DM199 as a disease-modifying therapy for preeclampsia. These developments reflect DiaMedica’s ongoing progress in advancing its clinical programs and securing financial resources.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.